Johnny Stilou

Chief Financial Officer

Education: MSc in Business Economics and Auditing, Executive Management Program, INSEAD

Background: Johnny Stilou has held numerous Executive positions as Chief Financial Officer within the biotech and pharmaceutical industry, most recently as CFO at Amgen Research Copenhagen and Nuevolution AB (acquired by Amgen). Prior to Nuevolution, he served as CFO at Veloxis Pharmaceuticals until the company was acquired by Asahi Kasei. 

Other ongoing assignments: None

Scandion Oncology shares and warrants
10,000 shares